Skip to Main Content

Paper Details

EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics.
Curr Cancer Drug Targets
145
2005
Author NameAffiliation
Renee C IretonVanderbilt Univesrity School of Medicine
  • 1 - 1

Datasets

Release 1.2